FDA issues warning about off‐label pediatric use of tramadol

Publisher： John Wiley & Sons Inc

E-ISSN： 1556-7567|17|11|8-8

ISSN： 1527-8395

Source： THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol.17, Iss.11, 2015-11, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study

By  

Current Drug Safety, Vol. 13, Iss. 3, 2018-11 ,pp. : 200-207

Bentham Science Publishers

Access to resources Recommend Favorite

Quality, Safety and Efficacy in the ‘Off-Label’ Use of Medicines

By  

Current Drug Safety, Vol. 2, Iss. 1, 2007-01 ,pp. : 89-95

Bentham Science Publishers

Access to resources Recommend Favorite

Off‐Label Use of Medicines: Time for Action

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 157-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Off-label drug use ‐ price analysis for Avastin ® in ophthalmology

By Michels Stephan   Kurz-Levin Malaika   Schmitz Christian  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 3, Iss. 1, 2009-04 ,pp. : 59-73

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Deleted: Requirement for Pharmacist Review of Off-Label Medication Use

By  

JCAH Perspectives, Vol. 31, Iss. 3, 2011-03 ,pp. : 4-4

Joint Commission Resources

Access to resources Recommend Favorite